Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025
Puma biotechnology press release 2025

Puma biotechnology press release 2025

Puma biotechnology press release 2025, Puma Biotech starts phase II trial for lung cancer therapy By 2025

$56.00

SKU: 7331888

Colour
  • Puma Biotechnology Presents Updated Results from the Phase II
  • Puma Biotechnology to Host Conference Call to Discuss Fourth
  • Puma Biotechnology Presents Updated Findings from the Phase II
  • Puma Biotechnology Reports Second Quarter Financial Results
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus